Remove CMS Remove Innovation Remove Pulmonary
article thumbnail

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

DAIC

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. JenaValve presented positive results of its U.S.

article thumbnail

The Evolving Computed Tomography Market

DAIC

Data was pulled from 2010–2019 Physician/Supplier Procedure Summary (PSPS) files obtained from the Centers for Medicare and Medicaid Services (CMS) website. According to the company, the Duo system adds high resolution thoracic clinical capability, suitable for screening lung cancer, COVID-19 and other pulmonary diseases.